Previous close | 6.00 |
Open | 6.00 |
Bid | 7.30 |
Ask | 9.60 |
Strike | 110.00 |
Expiry date | 2024-08-02 |
Day's range | 5.93 - 6.00 |
Contract range | N/A |
Volume | |
Open interest | 21 |
Dexcom (DXCM) and Abbott are set to launch their first FDA-approved over-the-counter CGMs, Stelo and Lingo & Libre Rio, respectively, in the United States this summer.
Key Insights Using the 2 Stage Free Cash Flow to Equity, DexCom fair value estimate is US$113 DexCom's US$113 share...
Smart rings and smartwatches are providing consumers with reams of health information. Clinical device makers like DexCom needn’t worry.